From Men's Health · Jocelyn Solis-Moreira · · 1m 40s
Trump Admin Bans Sleep Peptide
Trump administration blocks deep sleep peptide despite research claims.
In brief
Trump administration blocks deep sleep peptide despite research claims. The Trump administration banned emideltide, a sleep peptide, from compounding pharmacies due to safety concerns. Originally reported by Men's Health.
Quick answers
- What Is Emideltide?
- Emideltide is a nine-amino-acid peptide originally isolated from sleeping rabbits' blood in the late 1970s and administered via injection or nasal spray.
- What is the key takeaway from Trump Admin Bans Sleep Peptide?
- The Trump administration banned emideltide, a sleep peptide, from compounding pharmacies due to safety concerns.
Trump Admin Blocks Sleep Peptide
The Trump administration has not been shy about its pro-peptide stance, pushing to make six popular unapproved peptides available for compounding with prescriptions.
FDA Advisory Committee Voted
A recent FDA advisory committee meeting voted to add six out of seven peptides to a list of substances compounding pharmacies can manufacture and supply.
Emideltide Banned

Emideltide, also called DSIP, is the only peptide the FDA advisory board voted against moving out of the Category 2 list, a substance with significant safety risks.
What Is Emideltide?
Emideltide is a nine-amino-acid peptide originally isolated from sleeping rabbits' blood in the late 1970s and administered via injection or nasal spray.
Emideltide Claims
Reportedly helps users fall asleep faster, extend deep sleep, avoid waking multiple times, and improve vivid lucid dreaming.
Mixed Research Findings
Most research on emideltide's sleep effects occurred in the 1980s and 1990s with mixed results, including reduced sleep attacks and improved alertness in narcolepsy cases.
Sleep Trial Results
A clinical trial found emideltide users fell asleep quicker but placebo users outperformed after a second night, indicating inconsistent results.
Addiction Benefits
Emideltide reduced opioid withdrawal severity in 97% of people and alcohol withdrawal in 87% of alcohol addicts in 1984 studies.
Opioid Withdrawal Study
In 1998, seven people with opioid dependence reported improvements but the study noted it remains an open question whether emideltide could be an effective alternative detoxification approach.
The key point
The Trump administration banned emideltide, a sleep peptide, from compounding pharmacies due to safety concerns.
Read the TL;DR — this story on one card.



